Issuer Information

EDGAR: Contact Information
  • Name:
    NexPoint Life Sciences DST
  • Address:
    300 CRESCENT COURT
    SUITE 700
    DALLAS, TEXAS 75201
  • Phone:
    (833) 697-6246
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Other
  • Incorporated:
    Within 5 years (2021)
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
423917: 0001901493-22-000012
First Sale: 2021-12-16
Security Type(s): Equity
Offer Amount: $107,550,012
Amount Sold: $104,959,651
Remaining: $2,590,361
06b

AL, CA, CT, DC, GA, HI, IA, ID, IN, KS, KY, MA, MD, MN, NC, NH, NJ, NM, OH, OR, RI, TX, UT, VA, WI,

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.